Literature DB >> 15837432

Construction of human artificial chromosome vectors by recombineering.

George Kotzamanis1, Wing Cheung, Hassan Abdulrazzak, Sara Perez-Luz, Steven Howe, Howard Cooke, Clare Huxley.   

Abstract

Human artificial chromosomes (HACs) can be formed de novo by transfection of large fragments of cloned alphoid DNA into human HT1080 cells in tissue culture. In order to generate HACs carrying a gene of interest, one can either co-transfect the alphoid DNA and the gene of interest, or one can clone both into a single vector prior to transfection. Here we describe linking approximately 70 kb of alphoid DNA onto a 156-kb BAC carrying the human HPRT gene using Red homologous recombination in the EL350 Escherichia coli host [Lee et al., Genomics 73 (2001) 56-65]. A selectable marker and EGFP marker were then added by loxP/Cre recombination using the arabinose inducible cre gene in the EL350 bacteria. The final construct generates minichromosomes in HT1080 cells and the HPRT gene is expressed. The retrofitting vector can be used to add the approximately 70 kb of alphoid DNA to any BAC carrying a gene of interest to generate a HAC vector. The method can also be used to link any unrelated BAC or PAC insert onto another BAC clone. The EL350 bacteria are an excellent host for building up complex vectors by a combination of homologous and loxP/Cre recombination.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15837432     DOI: 10.1016/j.gene.2005.01.017

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  13 in total

Review 1.  Artificial and engineered chromosomes: developments and prospects for gene therapy.

Authors:  Brenda R Grimes; Zoia Larin Monaco
Journal:  Chromosoma       Date:  2005-10-15       Impact factor: 4.316

Review 2.  Human artificial chromosomes for gene delivery and the development of animal models.

Authors:  Yasuhiro Kazuki; Mitsuo Oshimura
Journal:  Mol Ther       Date:  2011-07-12       Impact factor: 11.454

3.  Organization of synthetic alphoid DNA array in human artificial chromosome (HAC) with a conditional centromere.

Authors:  Natalay Kouprina; Alexander Samoshkin; Indri Erliandri; Megumi Nakano; Hee-Sheung Lee; Haiging Fu; Yuichi Iida; Mirit Aladjem; Mitsuo Oshimura; Hiroshi Masumoto; William C Earnshaw; Vladimir Larionov
Journal:  ACS Synth Biol       Date:  2012-12-21       Impact factor: 5.110

4.  Assessing the functional characteristics of synonymous and nonsynonymous mutation candidates by use of large DNA constructs.

Authors:  A M Eeds; D Mortlock; R Wade-Martins; M L Summar
Journal:  Am J Hum Genet       Date:  2007-03-08       Impact factor: 11.025

Review 5.  A new generation of human artificial chromosomes for functional genomics and gene therapy.

Authors:  Natalay Kouprina; William C Earnshaw; Hiroshi Masumoto; Vladimir Larionov
Journal:  Cell Mol Life Sci       Date:  2012-08-21       Impact factor: 9.261

6.  Prospects for the use of artificial chromosomes and minichromosome-like episomes in gene therapy.

Authors:  Sara Pérez-Luz; Javier Díaz-Nido
Journal:  J Biomed Biotechnol       Date:  2010-08-24

Review 7.  Human artificial chromosome vectors meet stem cells: new prospects for gene delivery.

Authors:  Xianying Ren; Candice Ginn T Tahimic; Motonobu Katoh; Akihiro Kurimasa; Toshiaki Inoue; Mitsuo Oshimura
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 6.692

Review 8.  Bacterial artificial chromosome mutagenesis using recombineering.

Authors:  Kumaran Narayanan; Qingwen Chen
Journal:  J Biomed Biotechnol       Date:  2010-12-09

9.  Rapid generation of long synthetic tandem repeats and its application for analysis in human artificial chromosome formation.

Authors:  Tom Ebersole; Yasuhide Okamoto; Vladimir N Noskov; Natalay Kouprina; Jung-Hyun Kim; Sun-Hee Leem; J Carl Barrett; Hiroshi Masumoto; Vladimir Larionov
Journal:  Nucleic Acids Res       Date:  2005-09-01       Impact factor: 16.971

10.  A simplified, robust, and streamlined procedure for the production of C. elegans transgenes via recombineering.

Authors:  Yue Zhang; Lindsey Nash; Alfred L Fisher
Journal:  BMC Dev Biol       Date:  2008-12-30       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.